abrdn Life Sciences Investors DEF 14A Filing
Ticker: HQL · Form: DEF 14A · Filed: Apr 14, 2025 · CIK: 884121
| Field | Detail |
|---|---|
| Company | Abrdn Life Sciences Investors (HQL) |
| Form Type | DEF 14A |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, fund-filing
TL;DR
abrdn Life Sciences Investors filed its DEF 14A. Governance updates for healthcare funds.
AI Summary
abrdn Life Sciences Investors (formerly Tekla World Healthcare Fund) filed a DEF 14A on April 14, 2025, for the period ending May 28, 2025. The filing pertains to abrdn Healthcare Opportunities Fund and abrdn Healthcare Investors, both located at 1900 Market Street, Philadelphia, PA. These entities were formerly known as Tekla Healthcare Opportunities Fund and Tekla Healthcare Growth & Income Fund.
Why It Matters
This filing provides important governance and shareholder information for abrdn's healthcare-focused investment funds, impacting investor decisions and fund management oversight.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) providing information about the company's governance and shareholder matters, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- abrdn Life Sciences Investors (company) — Filer
- abrdn World Healthcare Fund (company) — Filer (formerly Tekla World Healthcare Fund)
- abrdn Healthcare Opportunities Fund (company) — Filer
- abrdn Healthcare Investors (company) — Filer
- Tekla World Healthcare Fund (company) — Former name
- Tekla Healthcare Opportunities Fund (company) — Former name
- Tekla Healthcare Growth & Income Fund (company) — Former name
- 1900 Market Street, Philadelphia, PA (location) — Business Address
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by companies to solicit proxies from shareholders for an upcoming annual or special meeting. It contains detailed information about matters to be voted on, including director elections, executive compensation, and other corporate governance issues.
When was this DEF 14A filing submitted?
This DEF 14A filing was submitted on April 14, 2025.
What is the reporting period for this filing?
The conforming period of report for this filing is May 28, 2025.
What were the former names of the abrdn entities mentioned?
abrdn World Healthcare Fund was formerly known as Tekla World Healthcare Fund. abrdn Healthcare Opportunities Fund was formerly known as Tekla Healthcare Opportunities Fund and Tekla Healthcare Growth & Income Fund.
Where are the business addresses for these abrdn funds located?
The business addresses for abrdn World Healthcare Fund, abrdn Healthcare Opportunities Fund, and abrdn Healthcare Investors are all listed as 1900 Market Street, Suite 200, Philadelphia, PA 19103.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 14, 2025 regarding abrdn Life Sciences Investors (HQL).